MedTrace Logo

Study of the Cardiovascular Vitamin, CardioLife

NCT02088307 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2016-03-22

No results posted yet for this study

Summary

Evaluation of the metabolic and physiological characteristics of patients with diagnosed Cardiovascular Disease following administration of the Cardiovascular vitamin, CardioLife.

Conditions

Interventions

DIETARY_SUPPLEMENT

CardioLife

Participants randomized to treatment arm will take dietary supplement as instructed.

Sponsors & Collaborators

Principal Investigators

  • Anwar Tandar, M.D. · University of Utah

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02088307 on ClinicalTrials.gov